Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

1800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The mainstay of treatment for atrial fibrillation remains pharmacological;however,catheter ablation has increasingly been used over the last decades. The relative merits of each strategy have not been extensively studied. Our study was designed to determine if catheter ablation is a feasible option as first-line therapy for treating patients with symptomatic AF.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety Study of Catheter Ablation for Atrial Fibrillation

NCT01113294

Atrial Fibrillation

UNKNOWN PHASE4

Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation

NCT04942834

Atrial Fibrillation, Persistent Arrhythmias, Cardiac

RECRUITING NA

An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia

NCT06157437

Typical Atrial Flutter Atrial Fibrillation (AF)

RECRUITING NA

The Influence of Catheter Ablation for Atrial Fibrillation on Atrial Electrical

NCT03322085

Atrial Fibrillation

COMPLETED NA

A New Approach for Catheter Ablation of Atrial Fibrillation

NCT05989321

Atrial Fibrillation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Antiarrythmic Drugs

Group Type ACTIVE_COMPARATOR

Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists

Intervention Type DRUG

ablation

Group Type EXPERIMENTAL

catheter ablation

Intervention Type PROCEDURE

circumferential pulmonary vein isolation complex fractionated atrial electrograms ablation circumferential pulmonary vein isolation combined left atrial roof ablation circumferential pulmonary vein isolation combined left atrial isthmus ablation circumferential pulmonary vein isolation combined left atrial roof and isthmus ablation circumferential pulmonary vein isolation combined complex fractionated atrial electrograms ablation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.